Small Molecule Inhibitors Simultaneously Targeting Cancer Metabolism and Epigenetics: Discovery of Novel Nicotinamide Phosphoribosyltransferase (NAMPT) and Histone Deacetylase (HDAC) Dual Inhibitors
Guoqiang Dong(Second Military Medical University), Chunquan Sheng(Second Military Medical University), Pei Wang(Icahn School of Medicine at Mount Sinai), Xinglin Yang(Indiana University School of Medicine), Xia Wang(Union Hospital), Tian‐Ying Xu(Second Military Medical University), Yu Rao(Soochow University), Wei Chen(Fujian Medical University), Wannian Zhang(Second Military Medical University), Chao‐Yu Miao(Second Military Medical University)
Cited by 107
Related Papers
PROTACs: great opportunities for academia and industry
|Signal Transduction and Targeted Therapy|2019|627
Use of Exome Sequencing for Infants in Intensive Care Units
|Archives of Pediatrics and Adolescent Medicine|2017|435
PROTAC Technology: Opportunities and Challenges
|ACS Medicinal Chemistry Letters|2020|353
Reanalysis of Clinical Exome Sequencing Data
|New England Journal of Medicine|2019|303